Philippa Roxby

1 week ago | yahoo.com | Philippa Roxby

A new type of drug for one of the most common kinds of advanced breast cancer is now available on the NHS in England. Some 3,000 women a year could benefit from capivasertib after a clinical trial showed it can slow progression of the disease, and shrink tumours in a quarter of people. The drug has been given the green light for NHS funding by England's drug assessment body.

4 weeks ago | bbc.com | Philippa Roxby

Baby slings unsafe for hands-free feeding, charities warnPhilippa RoxbyGetty ImagesChildbirth charities are warning parents that hands-free breastfeeding or bottle feeding, when a baby is being carried in a sling, is unsafe. The National Childbirth Trust (NCT) and the Lullaby Trust say the risks are highest for premature babies and those under four months old because their airways can be easily blocked.

1 month ago | businessandamerica.com | Philippa Roxby |Dominic Hughes

Philippa Roxby and Dominic HughesHealth correspondentsAbout 6,000 community pharmacies in England are, for the first time, being advised to start “working to rule” in two weeks, unless an agreement can be reached with the government on a new NHS contract. The National Pharmacy Association (NPA) is urging its members to limit opening hours to 40 a week, as set out in the current contract, because they have yet to receive any confirmation of funding for this or next financial year.

1 month ago | bbc.com | Philippa Roxby |Elena Bailey

New endometriosis pill approved on NHS in EnglandPhilippa Roxby and Elena BaileyGetty ImagesThe first daily pill for treating endometriosis symptoms has been approved for use on the NHS in England - but only for patients who have tried all other options. Endometriosis affects 1.5 million women in the UK, causing pain and extreme tiredness as a result of tissue similar to the womb lining growing elsewhere in the body.

1 month ago | yahoo.com | Philippa Roxby

An artificial-intelligence tool can detect two-thirds of epilepsy brain lesions doctors often miss, say the UK researchers who have developed it, paving the way for more targeted surgery to stop seizures. One out of every five people with epilepsy - a total of 30,000 in the UK - has uncontrolled seizures caused by brain abnormalities too subtle for the human eye to see on scans. Child epilepsy experts say the AI tool has "huge potential" and opens up avenues for treatment.